The burden of chronic pain in transgender and gender diverse populations: Evidence from a large <scp>US</scp> clinical database
Our study, featuring the largest cohort of Transgender and Gender Diverse (TGD) individuals assembled to date, reveals critical disparities in chronic pain among TGD populations, notably those on hormone therapy, compared with the cisgender population. It highlights the urgent need for specialized screening and treatment for this vulnerable population, and research into hormone therapy's impact on pain. These insights aim to foster more effective, personalized healthcare, enhancing the well-being and quality of life for the TGD community.
Authors
- Megan McNamara (ORCID: https://orcid.org/0000-0002-7324-3199)
- Shubham Gupta (ORCID: https://orcid.org/0000-0002-0364-5213)
- David Gilbert (ORCID: https://orcid.org/0000-0002-3334-5836)
- Kirtishri Mishra (ORCID: https://orcid.org/0000-0001-6468-7858)
- Tomasz Tabernacki (ORCID: https://orcid.org/0000-0003-0650-3349)
- Stephen Rhodes (ORCID: https://orcid.org/0000-0002-3811-8878)
- Kyle Scarberry (ORCID: https://orcid.org/0000-0001-9195-6873)
- Swagata Banik (ORCID: https://orcid.org/0000-0002-2751-1746)
- Rachel Pope (ORCID: https://orcid.org/0000-0002-1097-7611)
Institutions
- Baldwin Wallace University (US)
- MetroHealth (US)
- Louis Stokes Cleveland VA Medical Center (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- European Journal of Pain
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1002/ejp.4725
- Citations
- 5
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.22